A New Standard of Care for Cervical Fusion
The CORUS™ PCSS delivers superior patient outcomes and favorable hospital economics, addressing the costly challenges of 3-level ACDF procedures.
Discover The ValueThe Problem: A Costly Epidemic of Failed Fusions
The goal of spinal fusion is to provide a permanent solution, but for complex 3-level ACDF procedures, failure is a common and expensive problem for both patients and hospitals.
0%
of 3-Level ACDF Patients
require a secondary surgical intervention within two years, with symptomatic nonunion being the primary cause.¹
$0
Direct Cost of Revision Surgery
significantly eroding or negating the profitability of the initial procedure and burdening the healthcare system.²
The Solution: A New Standard of Care with CORUS™ PCSS
Providence Medical Technology's CORUS™ PCSS offers an integrated system for Circumferential Cervical Fusion (CCF), combining anterior and posterior approaches for a more stable, effective, and economically sound fusion.
A. Superior Patient Outcomes
Our technology delivers a durable solution, proven in the largest prospective randomized study on 3-level ACDF vs. CCF with PCSS. Patients experience higher fusion rates and a drastically lower need for repeat surgeries.¹
B. Favorable Hospital Economics
Implementing CORUS™ PCSS is a sound financial decision. The CCF procedure enhances reimbursement and profitability while mitigating the high costs of surgical failure, creating a win-win for patient care and hospital finances.
Increased Profitability
Over $10,000
in additional profit per patient from CCF procedure reimbursement.³٬⁴
Significant Cost Avoidance
$36,000
estimated direct cost avoided per patient by preventing revision surgeries.²
Clinical Evidence Deep Dive
The FUSE Study provides robust, prospective, randomized evidence supporting the clinical superiority of CCF with CORUS™ PCSS over ACDF alone. Explore the key data points from the study below.¹
| Metric | ACDF (N=91) | CCF with PCSS (N=92) | Difference |
|---|---|---|---|
| Composite Fusion Success | 18.7% (17) | 66.3% (61) | 47.6% |
| Bridging Bone (CT) | 25.3% (23) | 68.5% (63) | 43.2% |
| ROM < 2° | 51.6% (47) | 80.4% (74) | 28.8% |
All P values < 0.001
| Metric | ACDF | CCF with PCSS |
|---|---|---|
| 24-mo Composite Safety Endpoint | 22.8% (13) | 50.8% (30) |
| Any AE Related to Procedure | 65.0% (67) | 45.5% (45) |
| Any Serious AE Related to Device/Procedure | 24.3% (25) | 5.1% (5) |
Ready to Adopt a New Standard of Care?
The evidence is clear. The Providence Medical Technology CORUS™ PCSS and LX systems offer a clinically proven, economically sound solution. Let's partner to improve patient outcomes and your health system's bottom line.
